It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
In studies on the mechanism of DNA damage response where ionizing radiation is used as the DNA damaging agent, cells are often exposed to ionizing radiation on melting ice (corresponding to 0.8 °C). The purpose of this procedure is to inhibit cellular processes i.e. DNA repair. Low temperature at exposure has been shown to act in a radioprotective manner at the level of cytogenetic damage, but its mechanisms of action are poorly understood. The aim of the study was to analyze the effect of hypothermia at the level of formation and decay of NBS1, γH2AX, and 53BP1 foci, micronuclei, survival, cell cycle progression and oxidative stress in U2OS cells. The results show that hypothermia alone induced oxidative stress and foci. When applied in combination with radiation but only during the exposure time, it potentiated the formation of γH2AX and 53BP1 but not of NBS1 foci. When applied during irradiation and subsequent repair time, 53BP1 and NBS1 foci formed and decayed, but the levels were markedly lower than when repair was carried out at 37 °C. The frequency of micronuclei was elevated in cells irradiated at 0.8 °C, but only when analysed 20 h after irradiation which is likely due to a reduced G2 cell cycle block. Hypothermia reduced cell survival, both with and without radiation exposure. The temperature effect should be considered when cooling cells on melting ice to inhibit DNA repair in the induction of DNA damage.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Jan Kochanowski University, Department of Medical Biology, Institute of Biology, Kielce, Poland (GRID:grid.411821.f) (ISNI:0000 0001 2292 9126)
2 Jan Kochanowski University, Department of Medical Biology, Institute of Biology, Kielce, Poland (GRID:grid.411821.f) (ISNI:0000 0001 2292 9126); Institute of Nuclear Chemistry and Technology, Centre for Radiobiology and Biological Dosimetry, Warsaw, Poland (GRID:grid.418850.0) (ISNI:0000 0001 2289 0890)
3 Jan Kochanowski University, Department of Atomic Physics and Nanophysics, Institute of Physics, Kielce, Poland (GRID:grid.411821.f) (ISNI:0000 0001 2292 9126)
4 Holy Cross Cancer Center, Department of Medical Physics, Kielce, Poland (GRID:grid.411821.f)
5 Jan Kochanowski University, Department of Medical Biology, Institute of Biology, Kielce, Poland (GRID:grid.411821.f) (ISNI:0000 0001 2292 9126); Stockholm University, Centre for Radiation Protection Research, Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm, Sweden (GRID:grid.10548.38) (ISNI:0000 0004 1936 9377)